**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 6147-53-1 |Cobalt (II) acetate, tetrahydrate | 100 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 40 42/43 50/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Limited evidence of a carcinogenic effect. May
cause sensitization by inhalation and skin contact. Very toxic to
aquatic organisms, may cause long-term adverse effects in the aquatic
environment.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
May cause skin irritation. Prolonged and/or repeated contact may
cause irritation and/or dermatitis. May cause skin sensitization, an
allergic reaction, which becomes evident upon re-exposure to this
material.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May be harmful if swallowed. May cause allergic reaction.
Inhalation:
Causes delayed lung injury. May cause respiratory tract irritation.
May cause asthmatic attacks due to allergic sensitization of the
respiratory tract. May cause asthma and shortness of breath.
Chronic:
Cobalt compounds may cause cancer based upon animal studies.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. Get medical aid. Do NOT use
mouth-to-mouth resuscitation.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Use with adequate ventilation. Minimize dust generation and
accumulation. Avoid contact with skin and eyes. Keep container
tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 6147-53-1:
United Kingdom, WEL - TWA: (listed as cobalt compounds): 0.1 mg/m
TWA (as Co)
United Kingdom, WEL - STEL: (listed as cobalt compounds): 0.3 mg/
STEL (as Co)
Japan: (listed as cobalt compounds): 0.05 mg/m3 OEL (as Co)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: pink - red
Odor: acetic odor
pH: 6.8 (0.2M aq. soln)
Vapor Pressure: Not available.
Viscosity: Not applicable.
Boiling Point: Not available.
Freezing/Melting Point: 140 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Soluble in water.
Specific Gravity/Density: 380g/L (20C)
Molecular Formula: C4H6CoO4.4H2O
Molecular Weight: 249.0264
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. Hygroscopic: absorbs
moisture or water from the air.
Conditions to Avoid:
Incompatible materials, dust generation, exposure to moist air or
water.
Incompatibilities with Other Materials:
Strong oxidizers. .
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, oxides of cobalt.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 6147-53-1: AG3325000
LD50/LC50:
CAS# 6147-53-1: Draize test, rabbit, eye: 500 mg/24H Mild; Draize
test, rabbit, skin: 500 mg/24H Moderate; Oral, rat: LD50 = 708
mg/kg.
Carcinogenicity:
Cobalt (II) acetate, tetrahydrate -
IARC: Group 2B carcinogen (listed as Soluble cobalt (II) salts).
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S.
Hazard Class: 9
UN Number: 3077
Packing Group: III
IMO
Shipping Name: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S.
Hazard Class: 9
UN Number: 3077
Packing Group: III
RID/ADR
Shipping Name: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S.
Hazard Class: 9
UN Number: 3077
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 40 Limited evidence of a carcinogenic effect.
R 42/43 May cause sensitization by inhalation and
skin contact.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 22 Do not breathe dust.
S 24 Avoid contact with skin.
S 29 Do not empty into drains.
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 6147-53-1: 2
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 6147-53-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 6147-53-1 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/12/1997 Revision #6 Date: 5/10/2005
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Cobalt (II) Nitrate Hexahydrate
| 10026-22-9 |
|
Stearyl stearate
| 2778-96-3 |
|
Glycerine trioleate
| 122-32-7 |
|
5-Bromo-4-chloro-3-indoxyl-??-D-xylopyranoside
| 207606-55-1 |
|
Cobalt oxide
| 1307-96-6 |
|
2-(6-Bromonaphthyl)-??-D-xylopyranoside hydrate
| 0-01-1 |
|
5-(4-Fluorophenyl)valeric acid
| 24484-22-8 |
|
6-Methoxyindole
| 3189-13-7 |
|
Alpha,Alpha-Trehalose, 99+%
| 99-20-7 |
|
3-Amino-9-fluorenone
| 6276-05-7 |
|
Methyl linolenate
| 301-00-8 |
|
5-Bromo-4-chloro-3-indoxyl butyrate
| 129541-43-1 |
|
6-Amino-1-methyluracil, 97%
| 2434-53-9 |
|
2,3-Dimethylbenzofuran, 99%
| 3782-00-1 |
|
6-Amino-1-methyl-5-nitrosouracil, 97%
| 6972-78-7 |
|
2-Aminoethyl dihydrogen phosphate, 95%
| 1071-23-4 |
|
4-Iodophenoxymethyl polystyrene resin, 1% cross-linked with DVB,
| 00-01-1 |
|
Iodo polystyrene resin, 50-100 mesh
| 00-01-1 |
|
(+/-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl
| 98327-87-8 |
|
4,6-Dimethoxysalicylaldehyde
| 708-76-9 |
|
Acid orange 63
| 15792-50-4 |
|
N-BOC-L-tert-Leucine
| 62965-35-9 |
|
5-Nitro-3-pyrazolecarboxylic acid
| 198348-89-9 |
|
3,4,5-Trifluorophenylboronic acid
| 143418-49-9 |
|
2-Fluoro-4-hydroxybenzonitrile
| 82380-18-5 |
|
Guanosine Hydrate, 99%
| 118-00-3 |
|
(1S,2R)-2-Amino-1,2-diphenylethanol
| 23364-44-5 |
|
2-Amino-4-(trifluoromethyl)benzenethiol hydrochloride
| 4274-38-8 |
|
o-Toluic hydrazide
| 7658-80-2 |
|
Sodium glycocholate hydrate
| 207614-05-9 |
|
1,11-Undecanedicarboxylic acid, 94%
| 505-52-2 |
|
1-Decanesulfonic acid, sodium salt, 96%
| 13419-61-9 |
|
4-Chloro-5-(2-thienyl)thieno[2,3-d]pyrimidine, 97%
| 189681-04-7 |
|
2-Methyl-4-(2-thienyl)-1,3-thiazole, 90+%
| 21036-67-9 |
|
3-(Oxiran-2-ylmethoxy)benzaldehyde, 97%
| 22590-64-3 |
|
2-(1,4-Diazepan-1-yl)ethan-1-ol, 97%
| 53427-65-9 |
|
1-[3-Chloro-5-(trifluoromethyl)-2-pyridyl]-1,4-diazepane, 97%
| 231953-40-5 |
|
Cobalt (II) acetate tetrahydrate
| 6147-53-1 |
|
tert-Butyl 1,4-diazepane-1-carboxylate, 97%
| 112275-50-0 |
|
Tris-(4-Bromophenyl)-Aminium Hexachloro-Antimonate, 98%
| 24964-91-8 |
|
tert-Butyl n-(2-aminoethyl)carbamate, 97%
| 57260-73-8 |
|
5-(1,4-Diazepan-1-yl)-3-phenyl-1,2,4-thiadiazole, 97%
| 306934-71-4 |
|
tert-Butyl n-{2-[2-amino-4-(trifluoromethyl)anilino]ethyl}carbamate,
| 215655-42-8 |
|
tert-Butyl 4-(2-hydroxyethyl)piperazine-1-carboxylate, 97%
| 77279-24-4 |
|
1-[4-(Trifluoromethyl)pyrimidin-2-yl]-1,4-diazepane, 97%
| 238403-48-0 |
|
1-(2-Chloro-6-fluorobenzyl)-1,4-diazepane, 97%
| 244022-69-3 |
|
1-(4-Fluorobenzyl)-1,4-diazepane, 97%
| 76141-89-4 |
|
1-(2-Chloro-6-fluorobenzyl)piperazine, 97%
| 215655-20-2 |
|
1-(5-Nitro-2-pyridyl)-1,4-diazepane, 97%
| 287114-27-6 |
|
N-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]propane-1,3-diamine, 95+%
| 465514-63-0 |
|
|